As hospital leaders continue to feel pressure to improve patient outcomes and reduce costs, a new study reveals one reason why many organizations fall short.
Feb 1, 2016
A drug approved by the Food and Drug Administration (FDA) for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), ...
Feb 1, 2016
In a study to be presented on Feb. 4 in an oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, How ...
Feb 1, 2016
In a study to be presented on Feb. 5 in an oral plenary session, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, Cryopreserved ...
Feb 1, 2016
In a study to be presented on Feb. 4 in the oral plenary session, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers with the Eunice Kennedy Shriver National Institute ...
Feb 1, 2016
In a study to be presented on Feb. 4 in an oral concurrent session, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers with the University of Alabama at Birmingham, ...
Feb 1, 2016
